Stock listing

NASDAQ:PNT POINT Biopharma Global Inc Stock

Follow POINT Biopharma Global Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PNT

$12.50 USD

Close on Dec 29, 2023 · No longer trades

Jul 8, 2020 to last close +4.0% · weekly closes, Jul 8, 2020 – Dec 29, 2023
Lowest – highest close
$4.83 – $16.86 USDSince Jul 8, 2020 · lowest Dec 16, 2021 · highest Feb 11, 2021

Delisted NASDAQ:PNT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PNT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

POINT Biopharma Global Inc on 6ix

Decks
3 decks · latest Feb 25, 2022

Where POINT Biopharma Global Inc is listed

ListingExchangeCountryCurrency
NASDAQ:PNT · This page · DelistedNASDAQUnited StatesUSD
NASDAQ:RACA · DelistedNASDAQUnited StatesUSD
NASDAQ:TXAC · DelistedNASDAQUnited StatesUSD

Decks

DeckKindSlidesDate
Investor Presentation (February 2022)Investor deck47 slidesFeb 25, 2022
Investor Presentation (November 2021)Investor deck41 slidesNov 19, 2021
SPAC Merger (March 2021)SPAC merger26 slidesMar 15, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rajeev M Shah
Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past)
Director · Jun 23, 2021 – Jun 29, 2021 · Past
Bridget Martell
Other companies: Delcath Systems, Inc. (Director · Since at least May 23, 2024); Aligos Therapeutics, Inc. (Director · Since at least Nov 16, 2021); Achieve Life Sciences, Inc. (Director · Since at least Mar 15, 2021); Ayala Pharmaceuticals Inc (Director · Oct 18, 2023 – Oct 18, 2023 · Past); Kura Oncology, Inc. (Acting Chief Medical Officer · Feb 10, 2020 – Aug 24, 2020 · Past)
Director · Jun 12, 2023 – Jun 13, 2023 · Past
Michael Gray
Other companies: Upstream Bio, Inc. (CFO and COO · Since at least Oct 10, 2024); Enliven Therapeutics, Inc. (CFO & COO · Mar 11, 2020 – Feb 22, 2023 · Past); X4 Pharmaceuticals, Inc. (President, CEO and CFO, Director · Nov 15, 2017 – Nov 27, 2018 · Past)
Director · Jul 7, 2020 – Jul 7, 2020 · Past
Allan C SilberExecutive Chairman, Director · Jun 30, 2021 – Dec 22, 2023 · Past
Gerald L HogueDirector · Jun 30, 2021 – Dec 26, 2023 · Past
Jessica D JensenEVP Clinical Development · Jun 30, 2021 – Dec 27, 2023 · Past
Joe A McCannChief Executive Officer, Director · Jun 30, 2021 – Dec 22, 2023 · Past
Jonathan R GoodmanDirector · Jun 2, 2022 – Dec 26, 2023 · Past
William L DemersChief Financial Officer · Jun 30, 2021 – Dec 27, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about POINT Biopharma Global Inc.